Health Imaging (4/9) reports on survey data published in Academic Radiology which states that out of nearly 1,000 patients scheduled for a mammogram, only 34.7% were content with their breast screening plan. And more than half were willing to shell out at least $250-$500 for an MRI exam, particularly those with dense breasts.

Health Imaging (4/6) reports on research published in Radiology journal which states that digital breast tomosynthesis screening produces lower interval breast cancer rates compared to traditional digital mammography, adding to growing evidence supporting DBT as a top cancer screening tool.

Aunt Minnie (4/2) reports on a study published in the Journal of the National Cancer Institute which states that while U.S. mammography screening rates have rebounded since plunging in the first few months of the COVID-19 pandemic, there remains a large cumulative deficit due to missed appointments.

Medscape (4/1) reports that in high-risk women, abbreviated breast MRI protocols require shorter interpretation times while maintaining similar cancer detection rates compared to full-sequence magnetic resonance imaging, according to a recent analysis published in the Journal of Breast Imaging.

Good Morning America (2/12) presented a wellness piece citing a recent position statement from the Society of Breast Imaging which states that swollen lymph nodes from receiving COVID-19 vaccines could throw off results of a mammogram.